Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Prejzner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|November 5, 2002
[Transplantation of hemopoietic stem cells in treatment of chronic myeloid leukemia]A Hellmann, W Prejzner
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 1, 1993
[Evaluation of treatment outcome in patients with idiopathic thrombocytopenia in the years 1980-1982]W Prejzner, A Hellmann
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 28, 1998
[Large granular lymphocytic leukemia]I Wyszecka-Polk, W Prejzner
Bone Marrow Transplantation|July 5, 2006
Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcriptK Halaburda, W Prejzner, D Szatkowski, et al.
Clinical and Laboratory Haematology|September 17, 2003
Modification of the clonogenic capacity of bone marrow cells from normal individuals by the tyrosine kinase inhibitor STI571W Prejzner, W Knopińska-Posłuszny, J Mikołajczuk, et al.
Clinical and Laboratory Haematology|May 19, 2006
Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemiaJ M Zaucha, E Wyrowinska, W Prejzner, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|September 1, 1995
[Evaluation of bone marrow grafts and hemopoietic chimerism using PCR hypervariable sequencing with variable number tandem repeat sequences]J M Zaucha, R Pawłowski, A Welz, et al.
Bone Marrow Transplantation|July 12, 2005
Imatinib therapy prior to myeloablative allogeneic stem cell transplantationJ M Zaucha, W Prejzner, S Giebel, et al.
Leukemia|June 12, 2013
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinibV S Hoffmann, M Baccarani, D Lindoerfer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Polskie Archiwum Medycyny Wewnetrznej|November 5, 2002
[Transplantation of hemopoietic stem cells in treatment of chronic myeloid leukemia]A Hellmann, W Prejzner
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 1, 1993
[Evaluation of treatment outcome in patients with idiopathic thrombocytopenia in the years 1980-1982]W Prejzner, A Hellmann
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 28, 1998
[Large granular lymphocytic leukemia]I Wyszecka-Polk, W Prejzner
Bone Marrow Transplantation|July 5, 2006
Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcriptK Halaburda, W Prejzner, D Szatkowski, et al.
Clinical and Laboratory Haematology|September 17, 2003
Modification of the clonogenic capacity of bone marrow cells from normal individuals by the tyrosine kinase inhibitor STI571W Prejzner, W Knopińska-Posłuszny, J Mikołajczuk, et al.
Clinical and Laboratory Haematology|May 19, 2006
Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemiaJ M Zaucha, E Wyrowinska, W Prejzner, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|September 1, 1995
[Evaluation of bone marrow grafts and hemopoietic chimerism using PCR hypervariable sequencing with variable number tandem repeat sequences]J M Zaucha, R Pawłowski, A Welz, et al.
Bone Marrow Transplantation|July 12, 2005
Imatinib therapy prior to myeloablative allogeneic stem cell transplantationJ M Zaucha, W Prejzner, S Giebel, et al.
Leukemia|June 12, 2013
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinibV S Hoffmann, M Baccarani, D Lindoerfer, et al.
Pageof 1